Barclays’s 4D Molecular Therapeutics FDMT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $415K | Buy |
111,779
+14,737
| +15% | +$54.7K | ﹤0.01% | 3136 |
|
|
2025
Q1 | $312K | Sell |
97,042
-8,203
| -8% | -$26.4K | ﹤0.01% | 3111 |
|
|
2024
Q4 | $586K | Sell |
105,245
-9,603
| -8% | -$53.5K | ﹤0.01% | 2960 |
|
|
2024
Q3 | $1.24M | Buy |
114,848
+67,202
| +141% | +$726K | ﹤0.01% | 2489 |
|
|
2024
Q2 | $1M | Sell |
47,646
-173
| -0.4% | -$3.63K | ﹤0.01% | 2119 |
|
|
2024
Q1 | $1.52M | Sell |
47,819
-60,890
| -56% | -$1.94M | ﹤0.01% | 2119 |
|
|
2023
Q4 | $2.2M | Buy |
108,709
+34,774
| +47% | +$704K | ﹤0.01% | 2093 |
|
|
2023
Q3 | $941K | Sell |
73,935
-68,529
| -48% | -$872K | ﹤0.01% | 2132 |
|
|
2023
Q2 | $2.57M | Buy |
142,464
+85,235
| +149% | +$1.54M | ﹤0.01% | 1577 |
|
|
2023
Q1 | $984K | Buy |
57,229
+22,556
| +65% | +$388K | ﹤0.01% | 2148 |
|
|
2022
Q4 | $770K | Buy |
34,673
+23,297
| +205% | +$517K | ﹤0.01% | 2311 |
|
|
2022
Q3 | $91K | Buy |
11,376
+1,760
| +18% | +$14.1K | ﹤0.01% | 3448 |
|
|
2022
Q2 | $68K | Sell |
9,616
-2,340
| -20% | -$16.5K | ﹤0.01% | 3618 |
|
|
2022
Q1 | $181K | Buy |
+11,956
| New | +$181K | ﹤0.01% | 3371 |
|